Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16600976rdf:typepubmed:Citationlld:pubmed
pubmed-article:16600976lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C0140079lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C1122962lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:16600976lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:16600976pubmed:issue7lld:pubmed
pubmed-article:16600976pubmed:dateCreated2006-6-26lld:pubmed
pubmed-article:16600976pubmed:abstractTextThe aim of the study was to assess whether loss of PTEN and expression of insulin-like growth factor receptor 1 (IGFR-1) could be responsible for intrinsic resistance to the tyrosine kinase inhibitor (TKI) gefitinib.lld:pubmed
pubmed-article:16600976pubmed:languageenglld:pubmed
pubmed-article:16600976pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:citationSubsetIMlld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16600976pubmed:statusMEDLINElld:pubmed
pubmed-article:16600976pubmed:monthJullld:pubmed
pubmed-article:16600976pubmed:issn0923-7534lld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:BunnP APAJrlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:SantoroAAlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:BartoliniSSlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:FranklinW AWAlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:HirschF RFRlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:FinocchiaroGGlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:Varella-Garci...lld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:CrinoLLlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:CancellieriAAlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:MagriniEElld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:TalliniGGlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:ToschiLLlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:TrisoliniRRlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:MetriMMlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:CappuzzoFFlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:CeresoliG LGLlld:pubmed
pubmed-article:16600976pubmed:authorpubmed-author:DomenichiniIIlld:pubmed
pubmed-article:16600976pubmed:issnTypePrintlld:pubmed
pubmed-article:16600976pubmed:volume17lld:pubmed
pubmed-article:16600976pubmed:ownerNLMlld:pubmed
pubmed-article:16600976pubmed:authorsCompleteYlld:pubmed
pubmed-article:16600976pubmed:pagination1120-7lld:pubmed
pubmed-article:16600976pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:meshHeadingpubmed-meshheading:16600976...lld:pubmed
pubmed-article:16600976pubmed:year2006lld:pubmed
pubmed-article:16600976pubmed:articleTitleInsulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.lld:pubmed
pubmed-article:16600976pubmed:affiliationUniversity of Colorado Cancer Center, Department of Medicine/Medical Oncology and Pathology, Aurora, USA.lld:pubmed
pubmed-article:16600976pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16600976pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16600976lld:pubmed